← FDA DRUG APPROVALS

FDA ANDA · ANDA090065

METHADONE HYDROCHLORIDE

Sponsor: EPIC PHARMA LLC

APPLICATION
ANDA090065
TYPE
ANDA
ORIGINAL APPROVAL
2015-08-18
LATEST ACTION
2026-06-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METHADONE HYDROCHLORIDEPrescription
METHADONE HYDROCHLORIDE 10MG · TABLET · ORAL
METHADONE HYDROCHLORIDEPrescription
METHADONE HYDROCHLORIDE 5MG · TABLET · ORAL

Approval history

2026-06-18REMS · Supplement 18AP
2025-12-22Labeling · Supplement 17 · standardAP
2025-12-22Labeling · Supplement 16 · standardAP
2024-10-31REMS · Supplement 15AP
2024-01-12Labeling · Supplement 14 · standardAP
2023-12-08Labeling · Supplement 13 · standardAP
2023-12-08Labeling · Supplement 11 · standardAP
2023-12-08Labeling · Supplement 5 · standardAP
2023-12-08Labeling · Supplement 8 · standardAP
2023-12-08Labeling · Supplement 10 · standardAP
2018-09-18REMS · Supplement 9AP
2017-05-26REMS · Supplement 6AP
2016-09-30REMS · Supplement 4AP
2016-04-20REMS · Supplement 1AP
2015-08-18OriginalREMSAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →